ClinicalTrials.Veeva

Menu
D

DocTrials | Arizona Retina and Vitreous Consultants

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ranibizumab
Faricimab
Razuprotafib
Pemafibrate
IONIS-FB-LRx
RG7774
AVD-104
Triamcinolone Acetonide
Abicipar Pegol
AKB-9778

Parent organization

This site is a part of DocTrials

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 20 total trials

A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (SIGLEC)

Investigate the Safety, Pharmacokinetics, and Treatment effects of Single and Multi-dose of Intravitreal AVD-104 in participants with geographic atro...

Active, not recruiting
Macular Degeneration
Geographic Atrophy of the Macula
Drug: AVD-104
Drug: Avacincaptad

This study will assess corneal endothelial cells in participants with nAMD treated with PDS refilled every 24 weeks (Q24W).

Enrolling
Neovascular Age-related Macular Degeneration
Device: SUSVIMO PDS Implant
Drug: LUCENTIS (ranibizumab injection)

This study will evaluate the efficacy, safety, and pharmacokinetics of the PDS with Ranibizumab in participants with DME when treated every 24 weeks...

Active, not recruiting
Diabetic Macular Edema
Drug: PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
Drug: Ranibizumab refill exchange

This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with ne...

Enrolling
Neovascular Age-Related Macular Degeneration
Drug: PDS Implant with Ranibizumab 100 mg/mL

Trial sponsors

Roche logo
Jaeb Center for Health Research logo
Genentech logo
Allergan logo
A
C
E
Ionis Pharmaceuticals logo
X

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems